ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Appili to progress Phase III oral Covid-19 treatment trial
May 18, 2021Appili Therapeutics is set to continue its ongoing Phase III PRESECO trial of oral therapy, Avigan/Reeqonus (favipiravir), without modification to treat mild-to-moderate Covid-19. -
Dr. Reddy’s seeks approval from Health Canada for Covid-19 treatment
December 24, 2020Dr. Reddy’s Canada has filed an application with Health Canada on behalf of the consortium for Reeqonus (favipiravir) tablets for acute treatment of mild to moderate Covid-19 in adult patients.
Pharma Sources Insight January 2025
